Related Experiment Videos
[Hematologic aspects of heart transplantation]
E Goncalvesová1, J Fabián, J Pacák
1I. interná klinika Dérerovej Nemocnice s poliklinikou v Bratislave Slovakia.
Bratislavske Lekarske Listy
|May 1, 1997
Summary
Heart transplantation can lead to significant hematologic issues, including bleeding disorders and cytopenias. Managing these complications is crucial for patient outcomes after heart transplants.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Transplantation Immunology
Context:
- Heart transplantation is a vital treatment for end-stage heart failure.
- Hematologic complications are frequent and complex following this procedure.
Purpose:
- To review the primary hematologic problems encountered after heart transplantation.
- To highlight key complications such as hemostatic disorders, cytopenias, and lymphoproliferative diseases.
Summary:
- Perioperative bleeding stems from cardiopulmonary bypass, platelet dysfunction, and hyperfibrinolysis.
- Cytopenias affect up to 70% of patients, with multifactorial causes including infections and therapies.
- Post-transplant lymphoproliferative diseases occur in about 1.2% of patients, often requiring immunosuppression withdrawal.
Impact:
- Understanding these hematologic issues is essential for optimizing patient care and outcomes.
- Effective management strategies are critical for improving survival rates and quality of life post-transplant.